Items where authors include "Heymann, M.F."

Article

Chalopin, A., Tellez-Gabriel, M., Brown, H.K. et al. (4 more authors) (2018) Isolation of circulating tumor cells in a preclinical model of osteosarcoma: Effect of chemotherapy. Journal of Bone Oncology, 12. pp. 83-90. ISSN 2212-1374

Tellez-Gabriel, M., Ory, B., Lamoureux, F. et al. (2 more authors) (2016) Tumour heterogeneity: the key advantages of single-cell analysis. International Journal of Molecular Sciences, 17 (12). 2142. ISSN 1661-6596

Najm, A., Orr, C., Heymann, M.F. et al. (3 more authors) (2016) Success Rate and Utility of Ultrasound-guided Synovial Biopsies in Clinical Practice. Journal of Rheumatology, 43 (12). pp. 2113-2119. ISSN 0315-162X

Tellez-Gabriel, M., Brown, H.K., Young, R. et al. (2 more authors) (2016) The Challenges of Detecting Circulating Tumor Cells in Sarcoma. Frontiers in Oncology, 6. 222. ISSN 2234-943X

Hoornaert, A., d'Arros, C., Heymann, M.F. et al. (1 more author) (2016) Biocompatibility, resorption and biofunctionality of a new synthetic biodegradable membrane for guided bone regeneration. Biomedical Materials, 11 (4). 045012. ISSN 1748-6041

Heymann, D., Renema, N., Navet, B. et al. (2 more authors) (2016) RANK-RANKL signalling in cancers. Bioscience Reports, 36 (4). e00366. ISSN 1573-4935

Dumars, C., Nguyen, J.M., Gaultier, A. et al. (5 more authors) (2016) Dysregulation of macrophage polarization is associated with the metastatic process in osteosarcoma. Oncotarget, 7. pp. 78343-78354. ISSN 0032-0889

Heymann, D. orcid.org/0000-0001-7777-0669, Heymann, M.F. and Brown, H.K. (2015) Drugs in early clinical development for the treatment of osteosarcoma. Expert Opinion on Investigational Drugs. ISSN 1354-3784

Lamora, A., Talbot, J., Bougras, G. et al. (10 more authors) (2014) Overexpression of Smad7 Blocks Primary Tumor Growth and Lung Metastasis Development in Osteosarcoma. Clinical Cancer Research, 20 (19). pp. 5097-5112. ISSN 1078-0432

Ando, K., Heymann, M.F., Stresing, V. et al. (3 more authors) (2013) Current Therapeutic Strategies and Novel Approaches in Osteosarcoma. Cancers, 5 (2). pp. 591-616. ISSN 2072-6694

David, E., Tirode, F., Baud'huin, M. et al. (7 more authors) (2012) Oncostatin M Is a Growth Factor for Ewing Sarcoma. The American Journal of Pathology, 181 (5). pp. 1782-1795. ISSN 0002-9440

Chemel, M., Le Goff, B., Brion, R. et al. (10 more authors) (2012) Interleukin 34 expression is associated with synovitis severity in rheumatoid arthritis patients. Annals of the Rheumatic Diseases (ARD), 71 (1). pp. 150-154. ISSN 0003-4967

David, E., Blanchard, F., Heymann, M.F. et al. (4 more authors) (2011) The Bone Niche of Chondrosarcoma: A Sanctuary for Drug Resistance, Tumour Growth and also a Source of New Therapeutic Targets. Sarcoma, 2011. 932451. ISSN 1357-714X

Ory, B., Heymann, M.F., Kamijo, A. et al. (3 more authors) (2005) Zoledronic acid suppresses lung metastases and prolongs overall survival of osteosarcoma-bearing mice. Cancer, 104 (11). pp. 2522-2529. ISSN 0008-543X

Heymann, D. orcid.org/0000-0001-7777-0669, Ory, B., Blanchard, F. et al. (7 more authors) (2005) Enhanced tumor regression and tissue repair when zoledronic acid is combined with ifosfamide in rat osteosarcoma. Bone , 37 (1). pp. 74-86. ISSN 8756-3282

Cherrier, B., Gouin, F., Heymann, M.F. et al. (4 more authors) (2005) A new experimental rat model of osteosarcoma established by intrafemoral tumor cell inoculation, useful for biology and therapy investigations. Tumor Biology, 26 (3). pp. 121-130. ISSN 1010-4283

Book Section

Heymann, D. orcid.org/0000-0001-7777-0669 and Heymann, M.F. (2018) Osteoprotegerin. In: Choi, S., (ed.) Encyclopedia of Signaling Molecules, 2nd Edition. Springer . ISBN 978-3-319-67198-7

Heymann, M.F. and Heymann, D. orcid.org/0000-0001-7777-0669 (2017) Immune environment and osteosarcoma. In: Honoki, K. and Weiss, K.R., (eds.) Osteosarcoma: Biology, behaviour and mechanisms. IntechOpen , pp. 105-120. ISBN 978-953-51-3096-3